Buy Alert: These 3 Coronavirus Stocks Are Heading Higher

On October 6, the European Medical Agency (EMA) announced the start of its expedited regulatory process for Pfizer (NYSE: PFE) and BioNTechs (NASDAQ: BNTX) Messenger RNA COVID-19 vaccine candidate BNT162b2. The experimental vaccine is currently in Phase 3 trials, with more than 28,000 out of 37,000 participants having completed their final dose. In Phase 1/2 testing and preclinical studies, participants taking BNT162b2 developed neutralizing antibodies, which are small proteins that recognize certain components of a pathogen and prevent it from entering healthy cells.

You should check here to buy the best price guaranteed products.

Last News

Top dunks from Cleveland Cavaliers vs. Utah Jazz

Detroit Lions fans' anger with Dan Campbell turns to shock after win vs. Vikings

'9-1-1' Fans Can't Stop Applauding Jennifer Love Hewitt’s Latest Career News

Jets vs Eagles: C.J. Mosley talks Jets defense failure to execute, Eagles disrespect | Jets Post Game

Elderly Couple Claims They Were Removed From American Airlines Flight Over Prayer Shawl

Bernardo continues to shows his class for Man City